Inclusion Criteria:  Meets all criteria for participation in the Neurolief-sponsored MOOD clinical trial (NCT04279522) and has been randomized to a treatment group for the double-blind phase. Is willing and able to participate in up to 3 additional research visits for EEG data collections.  Exclusion Criteria:  none